As of 03 Nov 2026 06:50 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2023/004 (23 Jan 2023): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Senokot® syrup 7.5mg/5ml syrupaffected product · inferred from phrasing | Out of stock, as stated | w/c 6th March 2023precision: a month · window end 12 Mar 2023, derived from “w/c 6th March 2023” | notice of 23 Jan 2023 |
| Senokot® syrup 12 Years Plus 7.5mg/5ml syrupaffected product · inferred from phrasing | Out of stock, as stated | w/c 27th March 2023precision: a month · window end 02 Apr 2023, derived from “w/c 27th March 2023” | notice of 23 Jan 2023 |
| Senna tablets (7.5mg sennosides) and alternative laxativesnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 23 Jan 2023 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Senna tablets (7.5mg sennosides) and alternative laxatives — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Senokot
Grouping under review The name on this page has not been matched to one BNF chemical with enough confidence to assert it; nothing here is grouped until a reviewer confirms it.
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence not asserted — grouping under review where marked
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 23 Jan 2023. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 23 Jan 2023 | Medicine Supply Notification: Senokot® syrup and Senokot® 12 Years Plus syrup (both containing 7.5mg/5ml sennosides) | Supply notification | Tier 2 | MSN/2023/004 |
Also recorded under
No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
No NHS Scotland Medicine Supply Alert Notice on record matches this name. Scotland is a separate record (all Scotland alerts); absence here is not a statement about supply in Scotland.